Experimental Vaccine for Malaria in Adults in Mali

NCT00343005 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

54

Enrollment

NIH

Sponsor class

Conditions

Plasmodium Falciparum Malaria

Interventions

BIOLOGICAL: AMA1-C1
DRUG: AMA1-C1/alhydrogel Malaria Vaccine

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)